Skip to content

Faculty profile

Heinrike Schmeling

Back to faculty
ResearcherPediatricsUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+-Year Results From a Multicenter, Open-Label Study.

    Arthritis & rheumatology (Hoboken, N.J.) · 2026

  • Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodies.

    Arthritis research & therapy · 2026 · first author

  • Systemic and local autoantibody responses to extracellular matrix proteins define inflammatory phenotypes across arthropathies.

    Rheumatology (Oxford, England) · 2026

All 56 publications

Latest funding

  • Pharmacogenetics of juvenile idiopathic arthritis: A genome wide association study on the efficacy and toxicity of methotrexate and etanercept therapy

    CIHR · 2012 · Nominated PI

    $280,000
  • Pharmacogenetics of juvenile idiopathic arthritis - A genome wide association study on the efficacy and toxicity of methotrexate therapy

    CIHR · 2010 · Nominated PI

    $280,000
All 2 grants and awards
Something wrong or missing on this profile? Suggest a correction